Baricitinib Outperforms TNF Inhibitors in Pragmatic RA Trial ...Middle East

In a real-world trial, baricitinib was favored over TNF inhibitors in clinical and patient-reported outcomes after 12 weeks, but one expert cautioned about longer-term JAK inhibitor side effects. Medscape Medical News

Hence then, the article about baricitinib outperforms tnf inhibitors in pragmatic ra trial was published today ( Thursday 27/06/2024 - 03:49 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Baricitinib Outperforms TNF Inhibitors in Pragmatic RA Trial )

Also on site :

• Hundreds of flights delayed at O'Hare after pipe burst at air traffic control tower
• ‘High School Musical’ Turns 20 Today! See Where the Cast Is Now
• Two dead in floods & torrential rains sweeping through Tunisia